High-density Lipoprotein, Vascular Risk, Cancer and Infection: A Case of Quantity and Quality?

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|25|2917-2926

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.25, 2014-08, pp. : 2917-2926

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?

By  

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1494-1503

Bentham Science Publishers

Access to resources Recommend Favorite

Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality

By  

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3841-3857

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic use of the high-density lipoprotein protein and peptides

By Marchesi Marta   Sirtori Cesare R  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 3, 2006-03 ,pp. : 227-241

Informa Healthcare

Access to resources Recommend Favorite

High-Density Lipoprotein-Raising Strategies: Update 2010

By  

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1517-1530

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies for Modifying High-Density Lipoprotein Cholesterol: A Role for Nicotinic Acid

By Schachter Michael  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 6, 2005-12 ,pp. : 415-422

Springer Publishing Company

Access to resources Recommend Favorite